Lythgoe, Katrina A., Hall, Matthew, Ferretti, Luca, de Cesare, Mariateresa, MacIntyre-Cockett, George, Trebes, Amy, Andersson, Monique, Otecko, Newton, Wise, Emma L., Moore, Nathan, Lynch, Jessica, Kidd, Stephen, Cortes, Nicholas, Mori, Matilde, Williams, Rebecca, Vernet, Gabrielle, Justice, Anita, Green, Angie, Nicholls, Samuel M., Ansari, M. Azim, Abeler-Dörner, Lucie, Moore, Catrin E., Peto, Timothy E. A., Eyre, David W., Shaw, Robert, Simmonds, Peter, Buck, David, Todd, John A., Connor, Thomas R., Ashraf, Shirin, da Silva Filipe, Ana, Shepherd, James, Thomson, Emma C., Bonsall, David, Fraser, Christophe, Golubchik, Tanya, Bashton, Matthew, Nelson, Andrew, Smith, Darren, Young, Greg, Oxford Virus Sequencing Analysis Group (OVSG), and The COVID-19 Genomics UK (COG-UK) Consortium, (2021) SARS-CoV-2 within-host diversity and transmission. Science, 372 (6539). eabg0821. ISSN 0036-8075
|
Text
eabg0821.full.pdf - Published Version Available under License Creative Commons Attribution 4.0. Download (1MB) | Preview |
|
|
Text
abg0821-Lythgoe-SM.pdf - Supplemental Material Available under License Creative Commons Attribution 4.0. Download (2MB) | Preview |
Abstract
Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have enabled researchers to monitor its spread and to identify concerning new variants. Two important determinants of variant spread are how frequently they arise within individuals and how likely they are to be transmitted. To characterize within-host diversity and transmission, we deep-sequenced 1313 clinical samples from the United Kingdom. SARS-CoV-2 infections are characterized by low levels of within-host diversity when viral loads are high and by a narrow bottleneck at transmission. Most variants are either lost or occasionally fixed at the point of transmission, with minimal persistence of shared diversity, patterns that are readily observable on the phylogenetic tree. Our results suggest that transmission-enhancing and/or immune-escape SARS-CoV-2 variants are likely to arise infrequently but could spread rapidly if successfully transmitted.
Item Type: | Article |
---|---|
Additional Information: | Funding information: We gratefully acknowledge the UK COVID-19 Genomics Consortium (COG UK) for funding. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR), and Genome Research Limited, operating as the Wellcome Sanger Institute. The research was also supported by a Wellcome Core Award (203141/Z/16/Z) with additional funding from the NIHR Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. K.A.L. and M.A.A. were supported by The Wellcome Trust and The Royal Society (107652/Z/15/Z to K.A.L. and 220171/Z/20/Z to M.A.A.). M.H., L.F., M.d.C., G.M.C., N.O., L.A.D., D.B., C.F., and T.G. were supported by Li Ka Shing Foundation funding awarded to C.F. P.S. was supported by a Wellcome Investigator Award (WT103767MA). J.A.T. was supported by a Wellcome Core Award (203141/Z/16/Z). C.E.M. was supported by the Fleming Fund at the Department of Health and Social Care, UK; the Wellcome Trust (209142/Z/17/Z) and the Bill and Melinda Gates Foundation (OPP1176062). DWE is a Robertson Fellow and an NIHR Oxford BRC Senior Fellow. Matthew Bashton, Andrew Nelson, Darren Smith, Greg Young are members of the COVID-19 Genomics UK (COG-UK) consortium. |
Subjects: | B100 Anatomy, Physiology and Pathology B200 Pharmacology, Toxicology and Pharmacy C700 Molecular Biology, Biophysics and Biochemistry |
Department: | Faculties > Health and Life Sciences > Applied Sciences |
Depositing User: | Elena Carlaw |
Date Deposited: | 15 Jun 2021 11:32 |
Last Modified: | 31 Jul 2021 11:00 |
URI: | http://nrl.northumbria.ac.uk/id/eprint/46446 |
Downloads
Downloads per month over past year